Prenatal screening for fetal abnormalities in an accepted part of modern obstetric management. Improvements on current screening procedures need to address increased diagnostic efficacy and earlier diagnosis. This study evaluates diagnostic efficacy of PAPP-A and F beta-hCG in the detection of first
Aneuploidy screening in the first trimester
โ Scribed by Kevin Spencer
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 367 KB
- Volume
- 145C
- Category
- Article
- ISSN
- 1552-4868
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
There has been an increase in the use of fetal ultrasound in the first trimester over the last few years. This paper will review the published literature on first trimester ultrasound screening programmes for both aneuploidy and fetal structural abnormalities. 1997 by John Wiley & Sons, Ltd.
The objective of this study was to determined the inยฏuence of maternal weight, maternal smoking habits, gravidity, parity and fetal gender on the level of maternal serum marker used in ยฎrst trimester screening for Down syndrome. A total of 2449 singleton unaffected pregnancies from two centres were
Meta-analysis was used to calculate maternal serum marker distribution parameters for Down syndrome risk estimation in the first trimester. Data from 44 series were combined: relating to pregnancy associated plasma protein (PAPP)-A in 18, free human chorionic gonadotrophin (hCG) in 17, -fetoprotein